BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35149839)

  • 21. Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation.
    Umebayashi K; Stenmark H; Yoshimori T
    Mol Biol Cell; 2008 Aug; 19(8):3454-62. PubMed ID: 18508924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein phosphorylation profiling using an in situ proximity ligation assay: phosphorylation of AURKA-elicited EGFR-Thr654 and EGFR-Ser1046 in lung cancer cells.
    Chen TC; Liu YW; Huang YH; Yeh YC; Chou TY; Wu YC; Wu CC; Chen YR; Cheng HC; Lu PJ; Lai JM; Huang CY
    PLoS One; 2013; 8(3):e55657. PubMed ID: 23520446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA‑885‑3p inhibits docetaxel chemoresistance in lung adenocarcinoma by downregulating Aurora A.
    Cao J; Geng J; Chu X; Wang R; Huang G; Chen L
    Oncol Rep; 2019 Feb; 41(2):1218-1230. PubMed ID: 30431113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.
    Shao G; Wang R; Sun A; Wei J; Peng K; Dai Q; Yang W; Lin Q
    Mol Cancer; 2018 Feb; 17(1):24. PubMed ID: 29455656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.
    Smith CJ; Berry DM; McGlade CJ
    J Cell Sci; 2013 Mar; 126(Pt 6):1366-80. PubMed ID: 23418353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation.
    Li M; Kales SC; Ma K; Shoemaker BA; Crespo-Barreto J; Cangelosi AL; Lipkowitz S; Panchenko AR
    Cancer Res; 2016 Feb; 76(3):561-71. PubMed ID: 26676746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia.
    Tang J; Tu S; Lin G; Guo H; Yan C; Liu Q; Huang L; Tang N; Xiao Y; Pope RM; Rajaram MVS; Amer AO; Ahmer BM; Gunn JS; Wozniak DJ; Tao L; Coppola V; Zhang L; Langdon WY; Torrelles JB; Lipkowitz S; Zhang J
    J Exp Med; 2020 Apr; 217(4):. PubMed ID: 31999304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-Cbl negatively regulates TRAF6-mediated NF-
    Jang HD; Hwang HZ; Kim HS; Lee SY
    Cell Mol Biol Lett; 2019; 24():29. PubMed ID: 31123462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressed expression of Cbl-b by NF-κB mediates icotinib resistance in EGFR-mutant non-small-cell lung cancer.
    Zhang T; Zheng C; Hou K; Wang J; Zhang Y; Fan Y; Zhao H; Qu X; Liu Y; Kang J; Che X; Hu X
    Cell Biol Int; 2019 Feb; 43(2):98-107. PubMed ID: 29972257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
    Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
    Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression.
    Woo JK; Kang JH; Shin D; Park SH; Kang K; Nho CW; Seong JK; Lee SJ; Oh SH
    Mol Cancer Ther; 2015 Jul; 14(7):1693-704. PubMed ID: 25882311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
    Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
    J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors.
    Ice RJ; McLaughlin SL; Livengood RH; Culp MV; Eddy ER; Ivanov AV; Pugacheva EN
    Cancer Res; 2013 May; 73(10):3168-80. PubMed ID: 23539442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
    Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines.
    Liu N; Wang YA; Sun Y; Ecsedy J; Sun J; Li X; Wang P
    Respir Res; 2019 Oct; 20(1):230. PubMed ID: 31647033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B.
    Kwak SY; Kim BY; Ahn HJ; Yoo JO; Kim J; Bae IH; Han YH
    FEBS J; 2015 Apr; 282(8):1512-25. PubMed ID: 25691332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alisertib inhibits migration and invasion of EGFR-TKI resistant cells by partially reversing the epithelial-mesenchymal transition.
    Wang CY; Lee MH; Kao YR; Hsiao SH; Hong SY; Wu CW
    Biochim Biophys Acta Mol Cell Res; 2021 May; 1868(6):119016. PubMed ID: 33744274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The E3 ubiquitin ligase c-Cbl mediates integrin β1 ubiquitination during dilated cardiomyopathy.
    Yang N; Yu F; Shao G; Fu Y; Kong W
    Biochem Biophys Res Commun; 2016 Oct; 479(4):728-735. PubMed ID: 27693578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
    Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
    Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
    Tan YC; Mirzapoiazova T; Won BM; Zhu L; Srivastava MK; Vokes EE; Husain AN; Batra SK; Sharma S; Salgia R
    Sci Rep; 2017 Aug; 7(1):9192. PubMed ID: 28835699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.